
Loading, please wait...

Loading, please wait...

Chronic daily headache (CDH) affects millions of adults globally, often leading to significant disability and reduced quality of life. While standard preventive medications exist, many patients experience limited efficacy or intolerable side effects. Recent clinical evidence suggests that acupuncture for chronic headache prophylaxis offers a promising, evidence-based solution for long-term management.
A comprehensive systematic review and meta-analysis of 22 randomized controlled trials (RCTs) involving 1,449 patients provides robust evidence regarding this intervention. The researchers found that acupuncture significantly reduces headache frequency compared to standard care or placebo interventions. Specifically, acupuncture led to a mean difference in headache frequency of -0.32 and reduced headache days by 0.72 per month. Moreover, patients reported a substantial decrease in headache intensity and duration. Additionally, those receiving acupuncture required fewer analgesic medications for breakthrough pain. These improvements remained consistent across various CDH subtypes, including chronic migraine and chronic tension-type headaches.
In addition to its efficacy, acupuncture demonstrated a high safety profile throughout the meta-analysis. The study noted that adverse events were generally mild and transient. Furthermore, subgroup analyses indicate that the treatment modality and duration significantly influence clinical outcomes. Consequently, clinicians should consider acupuncture as a viable non-pharmacological strategy for prophylactic care. The integration of this traditional therapy into modern pain management protocols could improve patient adherence. Therefore, practitioners can confidently recommend acupuncture as a safe adjunct to conventional therapies.
Yes, meta-analysis data shows that acupuncture is effective across multiple CDH subtypes, including chronic migraine and chronic tension-type headaches, by reducing frequency and intensity.
No, clinical trials consistently demonstrate that acupuncture is safe and well-tolerated, with minimal and mild adverse effects compared to many traditional prophylactic medications.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Nie Y et al. Utility of Acupuncture Therapy for Adult Chronic Daily Headache Prophylaxis: A Systematic Review and Meta-Analysis. Med Sci Monit. 2026 May 24. doi: 10.12659/MSM.952359. PMID: 42177613.
Vickers AJ, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018;19(5):455-474.
Linde K, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;(6):CD001218.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review of 22 RCTs demonstrates that acupuncture effectively reduces the frequency and intensity of chronic daily headaches with high safety....
4 months ago

Evaluating the Endothelial Activation and Stress Index (EASIX) provides critical prognostic insight into in-hospital mortality for patients with NSTEMI. Combining routine admission biomarkers like LDH, creatinine, and platelets enables rapid, cost-effective risk stratification in emergency and intensive cardiac care.
Today

The ClinGen Prenatal Gene Curation Expert Panel evaluated 63 disease relationships across 61 genes, establishing clinical validity for severe fetal phenotypes like hydrops and stillbirth to enhance prenatal genomic interpretation and clinical care.
Yesterday

A cohort study demonstrates that the weight-adjusted waist index predicts all-cause and cardiovascular mortality more accurately than BMI and conventional adiposity metrics, offering clinicians a practical anthropometric tool for superior cardiometabolic risk stratification.
Today

New research reveals that HOXD13 regulates primary cilia signalling and genomic stability in distal synovial fibroblasts, uncovering why conditions like rheumatoid arthritis target specific joints.
Today

A real-world observational study evaluates pediatric isolated growth hormone deficiency patients transitioning to once-weekly somatrogon, showing sustained height velocity, early IGF-1 shifts, and stabilized BMI.
Today